Rehab for alcoholism works, but not in the way most people imagine. It’s not a one-time fix with a guaranteed outcome. About 60% to 69% of people relapse within six months of completing treatment, which sounds discouraging until you put it in context: roughly three out of four Americans who say they’ve ever had a substance use problem consider themselves in recovery or recovered today. The path to lasting sobriety often involves setbacks, but treatment dramatically improves the odds of getting there.
What the Numbers Actually Look Like
The most consistent finding across studies is that 50% to 70% of people who complete treatment report abstinence at follow-up assessments between 3 and 18 months later. That’s the optimistic framing. The less optimistic one: at least 60% of people treated for alcohol use disorder return to hazardous drinking within six months. Both statistics are true, and the gap between them reflects differences in how studies define success, how long they follow people, and which patients they track.
The first three months after treatment are the most dangerous. Clinicians call this the “initial” period, when relapse risk is highest. From three months to one year, stability improves but remains fragile. People who stay sober for one to five years are in a much stronger position, and those who pass the five-year mark are significantly more likely to stay in remission long term.
A 2024 national survey from SAMHSA found that among the 31.7 million U.S. adults who felt they’d had a problem with drugs or alcohol, 74.3%, about 23.5 million people, said they were in recovery or had recovered. That number includes people who took multiple attempts to get there, but it signals that long-term recovery is far more common than the early relapse statistics suggest.
Inpatient vs. Outpatient: Does Setting Matter?
For most people, it doesn’t. Multiple randomized trials have found that intensive outpatient programs produce outcomes comparable to residential (inpatient) care. Both settings show significant reductions in drinking and improvements in functioning at follow-up. One smaller study did find higher abstinence at three months for inpatient patients (63% vs. 38%), but that difference disappeared by six months.
The exception is people with severe alcohol problems, psychiatric conditions, or recent suicidal thoughts. These groups tend to do better in residential settings, where 24-hour structure and monitoring provide a safety net that outpatient care can’t match. For everyone else, the choice between inpatient and outpatient often comes down to practical factors like cost, work obligations, and family responsibilities rather than a meaningful difference in effectiveness.
How Treatment Approach Affects Outcomes
The two dominant therapy models, cognitive behavioral therapy (CBT) and 12-step facilitation, perform about equally well. A large study of over 3,000 patients across 15 treatment programs found that while 12-step participants were slightly more likely to be abstinent at one year, both approaches were equally effective at reducing substance use and improving overall functioning. Programs that combined both methods showed similar results. This held true even when researchers looked only at the “purest” versions of each approach.
What seems to matter more than the specific therapy is whether you stay engaged long enough. Completing the full course of treatment, whatever that course looks like, consistently predicts better outcomes than dropping out early. A 90-day program isn’t inherently three times better than a 30-day one, but the pattern across research is clear: longer engagement with treatment correlates with more sustained recovery.
What Medication Adds
Two FDA-approved medications can reduce relapse when combined with therapy. Acamprosate, which helps reduce cravings, prevents one additional person from returning to drinking for every 11 treated (compared to a placebo). Oral naltrexone, which blocks the pleasurable effects of alcohol, prevents one additional person from relapsing for every 18 treated. These are modest effects on their own. Acamprosate reduces the risk of returning to any drinking by about 12%, and naltrexone by about 7%.
These numbers may seem small, but they represent a meaningful boost on top of behavioral therapy. Medication works best as one component of a broader treatment plan, not as a standalone solution.
Why Aftercare Changes the Trajectory
What happens after formal treatment ends may be more important than the treatment itself. Sober living houses illustrate this clearly. In one study, residents of a sober living program went from 11% abstinence at baseline to 68% at both 6 and 12 months. At 18 months, abstinence dipped to 46% but remained far above where it started. A second sober living model showed abstinence climbing from 20% to around 40-45% and holding steady through 18 months.
The underlying principle is straightforward: a stable, alcohol-free environment after treatment removes one of the biggest obstacles to staying sober. This doesn’t have to mean a sober living house specifically. Regular support group attendance, ongoing outpatient counseling, and changes to social routines all serve a similar function by keeping recovery active rather than letting it become something that ended when you left the facility.
Factors That Predict Relapse
Not everyone faces the same relapse risk. Research on veterans completing residential treatment identified three significant predictors of relapse within six months: symptoms of anhedonic depression (the inability to feel pleasure, a specific type of depressive symptom), cigarette smoking, and fewer days of sobriety before entering treatment. The more severe someone’s dependence and the more co-occurring mental health issues they carry, the harder the early months of recovery tend to be.
This is why comparing rehab success rates to, say, surgery success rates misses the point. Alcohol use disorder is a chronic condition shaped by biology, mental health, environment, and behavior all at once. Treatment addresses all of these to varying degrees, but it can’t eliminate them. The people who do best tend to be those who treat recovery as an ongoing process rather than a single event, adjusting their support systems and coping strategies over months and years rather than expecting a 30 or 90-day program to resolve everything permanently.
What “Success” Really Means
Clinicians now define recovery in stages. Initial remission covers the first three months, when risk is highest. Early remission spans three months to one year. Sustained remission means one to five years without meeting diagnostic criteria (other than occasional craving, which is expected). Stable remission, beyond five years, is where the odds of lasting recovery become strong.
This framework matters because it redefines what you should expect from rehab. The goal of treatment isn’t to make you permanently sober in one attempt. It’s to give you the tools, strategies, and neurological support to move through these stages. Some people do it on the first try. Many don’t. But each treatment episode builds skills and self-awareness that make the next attempt more likely to stick, and the national data on recovery rates suggest that persistence pays off for the majority of people who keep at it.